Navigating the Uncommon: Case Report of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) Successfully Managed with Implantable Cardioverter Defibrillator (ICD)
Main Article Content
Abstract
With a high risk of sudden cardiac mortality, arrhythmogenic right ventricular cardiomyopathy (ARVC) is a rare inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmias (VA). In this case study, a 35-year-old presented with palpitations and revealed epsilon waves on the right precordial electrocardiogram (ECG) leads which led to the suspicion of ARVC. A 24-hour Holter monitoring revealed frequent ventricular extrasystoles (>500 per 24 hours), a CMRI revealed RV dyskinesia and transmural LGE in the apical RV, and an electrophysiologic study detected spontaneous polymorphic ventricular tachycardia (VT) despite the presence of induction ventricle fibrillation (VF). These results validated the diagnosis of ARVC and indicated that an implantable cardioverter defibrillator was necessary treatment. The ability to identify potential ARVC’s ECG abnormalities, the timing to pursue further studies, and determining necessary treatment execution are critical. The evaluation of cardiac, electrophysiological, and clinical imaging parameters is essential for the risk stratification, diagnosis, and management of patients with ARVC.
Downloads
Article Details
Copyright (c) 2024 Sidhi Laksono Purwowiyoto, Hermawan, Hillary Kusharsamita

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Alblaihed L, Kositz C, Brady WJ, Al-Salamah T, Mattu A. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Am J Emerg Med. 2023 Mar 1;65:146–53.
Shah SN, Umapathi KK, Oliver TI. Arrhythmogenic Right Ventricular Cardiomyopathy. StatPearls [Internet]. 2023 Jul 24 [cited 2024 Feb 5]; Available from: https://www.ncbi.nlm.nih.gov/books/NBK470378/
Khan Z, Abumedian M, Yousif Y, Gupta A, Myo SL, Mlawa G. Arrhythmogenic Right Ventricular Cardiomyopathy in a Patient Experiencing Out-of-Hospital Ventricular Fibrillation Arrest Twice: Case Report and Review of the Literature. Cureus [Internet]. 2022 Jan 20 [cited 2024 Feb 5];14(1). Available from: /pmc/articles/PMC8857986/
Romero J, Mejia-Lopez E, Manrique C, Lucariello R. Arrhythmogenic right ventricular cardiomyopathy (ARVC/D): A systematic literature review. Clin Med Insights Cardiol [Internet]. 2013 May 21 [cited 2024 Feb 5];7(7):97–114. Available from: http://www.la-press.com.
Alblaihed L, Kositz C, Brady WJ, Al-Salamah T, Mattu A. Diagnosis and management of arrhythmogenic right ventricular cardiomyopathy. Am J Emerg Med. 2023 Mar 1;65:146–53.
Ruwald AC, Marcus F, Estes NAM, Link M, McNitt S, Polonsky B, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J [Internet]. 2015 Jul 14 [cited 2024 Feb 5];36(27):1735–43. Available from: https://pubmed.ncbi.nlm.nih.gov/25896080/
Sattar Y, Abdullah HM, Samani EN, Myla M, Ullah W. Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An Updated Review of Diagnosis and Management. Cureus [Internet]. 2019 Aug 13 [cited 2024 Feb 5];11(8). Available from: /pmc/articles/PMC6786836/
Graziano F, Zorzi A, Cipriani A, De Lazzari M, Bauce B, Rigato I, et al. The 2020 “Padua Criteria” for Diagnosis and Phenotype Characterization of Arrhythmogenic Cardiomyopathy in Clinical Practice. J Clin Med [Internet]. 2022 Jan 1 [cited 2024 Feb 5];11(1). Available from: /pmc/articles/PMC8746198/
Calkins H, Corrado D, Marcus F. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy. Circulation [Internet]. 2017 Nov 1 [cited 2024 Feb 5];136(21):2068–82. Available from: https://www.ahajournals.org/doi/abs/10.1161/circulationaha.117.030792
Ban JE, Park HC, Park JS, Nagamoto Y, Choi JI, Lim HE, et al. Electrocardiographic and electrophysiological characteristics of premature ventricular complexes associated with left ventricular dysfunction in patients without structural heart disease. Europace. 2013 May;15(5):735–41.
Bhonsale A, James CA, Tichnell C, Murray B, Gagarin D, Philips B, et al. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. J Am Coll Cardiol [Internet]. 2011 Sep 27 [cited 2024 Feb 5];58(14):1485–96. Available from: https://pubmed.ncbi.nlm.nih.gov/21939834/
Latt H, Aung TT, Roongsritong C, Smith D. A classic case of arrhythmogenic right ventricular cardiomyopathy (ARVC) and literature review. J Community Hosp Intern Med Perspect [Internet]. 2017 Apr 3 [cited 2024 Feb 5];7(2):115. Available from: /pmc/articles/PMC5473197/
Mazzanti A, Ng K, Faragli A, Maragna R, Chiodaroli E, Orphanou N, et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk. J Am Coll Cardiol [Internet]. 2016 Dec 13 [cited 2024 Feb 5];68(23):2540–50. Available from: https://pubmed.ncbi.nlm.nih.gov/27931611/
Schinkel AFL. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol [Internet]. 2013 Jun [cited 2024 Feb 5];6(3):562–8. Available from: https://www.ahajournals.org/doi/abs/10.1161/CIRCEP.113.000392